Keyphrases
Alzheimer's Disease
100%
Parkinson's Disease
100%
Risk Reduction
100%
Bacillus Calmette-Guérin
100%
Bladder Cancer Therapy
100%
Bladder Cancer
30%
Cancer Patients
30%
Neurodegenerative Diseases
20%
Hazard Ratio
20%
Beneficial Effects
20%
Immune Effect
20%
Non-muscle Invasive Bladder Cancer (NMIBC)
20%
Dementia
10%
Immune System
10%
Inoculation
10%
Elderly People
10%
Low Risk
10%
Mycobacterium Bovis
10%
Risk Analysis
10%
Live Attenuated
10%
Type 2 Diabetes Mellitus (T2DM)
10%
Inclusion Criteria
10%
Age-related
10%
Older Population
10%
Multicenter Retrospective Cohort Study
10%
Non-vascular
10%
Patient Data
10%
Protective Agents
10%
Tuberculosis
10%
Repeated Exposure
10%
Cox Proportional Hazards Regression
10%
Transurethral Resection of Bladder Tumor (TURBT)
10%
Bacillus Calmette-Guérin Therapy
10%
Disjoint Groups
10%
Intravesical
10%
Nonspecific Immune Response
10%
Hospital-based Cohort
10%
Two-stroke
10%
Medicine and Dentistry
Bladder Cancer
100%
Alzheimer's Disease
100%
Cancer Immunotherapy
100%
Parkinson's Disease
100%
Mycobacterium Bovis BCG
100%
Hazard Ratio
16%
Degenerative Disease
16%
Immunity
16%
Non Muscle Invasive Bladder Cancer
16%
Proportional Hazards Model
8%
Retrospective Cohort Study
8%
Apoplexy
8%
Prospective Study
8%
Patient-Data
8%
Immune System
8%
Maturity Onset Diabetes of the Young
8%
Bladder Tumor
8%
Intravesical Drug Administration
8%
Protective Agent
8%
Transurethral Resection
8%
Mycobacterium bovis
8%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Bladder Cancer
100%
Alzheimer's Disease
100%
Parkinson's Disease
100%
Mycobacterium Bovis BCG
100%
Degenerative Disease
16%
Non Muscle Invasive Bladder Cancer
16%
Prospective Study
8%
Cohort Study
8%
Cerebrovascular Accident
8%
Bladder Tumor
8%
Protective Agent
8%
Mycobacterium bovis
8%
Non Insulin Dependent Diabetes Mellitus
8%
Neuroscience
Alzheimer's Disease
100%
Parkinson's Disease
100%
Cancer Immunotherapy
100%
Neurodegenerative Disorder
28%
Cerebrovascular Accident
14%